Target intelligence / Profile preview

Fanconi anemia complementation group A (FANCA)

Target
FANCA
Molecular classification
DNA repair protein, Transcription factor
01

Overview

The FANCA gene encodes a protein that is a core component of the Fanconi anemia (FA) pathway, which is crucial for DNA repair, specifically the repair of interstrand cross-links (ICLs). The FA pathway is activated when DNA replication stalls due to damage. FANCA forms part of the FA core complex, which monoubiquitinates FANCD2 and FANCI, recruiting downstream DNA repair machinery. Mutations in FANCA are responsible for a large proportion of Fanconi anemia cases.

02

Mechanism of action

N/A

03

Biological functions

DNA repairInterstrand cross-link (ICL) repairCell cycle checkpoint controlHomologous recombination repairSignal transduction
04

Disease associations

Fanconi anemiaBone marrow failureCancer predispositionAcute myeloid leukemia
05

Safety considerations

Loss-of-function mutations lead to genomic instability and increased cancer risk
06

Biomarkers

Monoubiquitinated FANCD2 (absence/reduction indicates FANCA defects)

Beyond the preview

Go deeper on Fanconi anemia complementation group A (FANCA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fanconi anemia complementation group A (FANCA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call